PROIMMUNE - Key Persons
Before co-founding ProImmune with Nik Schwabe, Linda completed her D.Phil. at the Institute of Molecular Medicine at Oxford in the laboratory of Prof. Andrew McMichael where her work focused on T cell immunology and the MHC pathway. Linda holds a D.Phil. in Molecular Immunology and a B.A. in Biochemistry, both from Oxford University.
Dr Linda Tan and Dr Nikolai Schwabe founded ProImmune in 2000. The business has never relied on outside investment, and this independence from external investors continues to allow ProImmune to pursue its own business direction. The company developed building on Linda's PhD work at Oxford's Weatherall Institute of Molecular Medicine.
Among ProImmune's early products were Pro5® MHC Pentamers, which are used to detect epitope-specific immune cells so that they can be analyzed in human blood samples. Pentamers, as well as ProT2® MHC Class II Tetramers introduced in 2016, continue to be part of ProImmune's core business and have gone from strength to strength with more than 1800 peer reviewed publications citing the use of these products.
ProImmune has pro-actively maintained links with its academic roots and contributed to diverse collaborative projects over the years. The company's motto ‘Mastering Immunity' reflects the importance to medical science of understanding how the immune system functions.
Prior to co-founding ProImmune with Linda Tan, Nik worked in the fiber optics industry at Bookham Technology and in investment banking at Salomon Brothers, now part of Citigroup. Nik holds a D.Phil. in Theoretical Physics from Oxford University.